60mg dose not in phase 3 showed 19% NASH Resolution
80 mg dose in phase 2 trial = 38% resolution
Better is that the phase 3 trial has a 100mg arm and with the safety data coming in it looks like the ideal dose for an even higher resolution percentage.
Also, the company has been in talks with multiple Big Pharma about partnering. Madrigal feel confident enough that they feel no partnering will take place until after the final phase 3 data is presented in 2022.
Glad this one is off the radar and may give me another chance to add shares at lower prices.
Recent MDGL News
- Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 06/17/2025 08:05:00 PM
- Madrigal Pharmaceuticals to Participate in the 46th Annual Global Goldman Sachs Health Care Conference • GlobeNewswire Inc. • 06/02/2025 12:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/14/2025 04:15:20 PM
- Madrigal Announces New Clinical Data Demonstrating Rezdiffra™ (resmetirom) Significantly Improved Multiple Noninvasive Tests and Portal Hypertension Risk in Patients with Compensated MASH Cirrhosis • GlobeNewswire Inc. • 05/10/2025 11:15:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/01/2025 12:53:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2025 11:02:50 AM
- Madrigal Pharmaceuticals Reports First-Quarter 2025 Financial Results and Provides Corporate Updates • GlobeNewswire Inc. • 05/01/2025 11:00:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/29/2025 08:21:46 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/29/2025 08:16:49 PM
- Madrigal to Present Late-Breaking Resmetirom Data in Patients with Compensated MASH Cirrhosis at the EASL Congress • GlobeNewswire Inc. • 04/29/2025 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/24/2025 09:03:13 PM
- Madrigal Pharmaceuticals to Release First-Quarter 2025 Financial Results and Host Webcast on May 1, 2025 • GlobeNewswire Inc. • 04/18/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/17/2025 08:52:52 PM
- Madrigal Pharmaceuticals Announces Company Founder Rebecca Taub, M.D. to Become Senior Scientific and Medical Advisor; David Soergel, M.D., Appointed Chief Medical Officer • GlobeNewswire Inc. • 04/16/2025 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2025 08:32:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2025 08:29:06 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2025 08:24:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2025 12:05:15 PM
- Madrigal Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of Directors • GlobeNewswire Inc. • 03/11/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2025 10:47:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2025 10:43:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2025 10:00:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2025 09:50:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2025 09:31:44 PM
FEATURED ePIC Blockchain Signs LOI with A.R.T. Digital to Redefine Bitcoin Miner Design with Breakthrough Air-Cooling Technology • Jun 18, 2025 12:41 PM
Authentic Holdings Inc. Partnership with Swerve TV Debuts with Highly Successful 'Ring of Combat' Live Broadcast • AHRO • Jun 18, 2025 12:45 PM
Avant Technologies' JV Partner, Ainnova, Begins Diabetic Retinopathy Screenings with Leading Pharmacies • AVAI • Jun 17, 2025 8:00 AM
Cannabix Technologies Receives Notice of Allowance from USPTO for Contactless Breath Analysis • BLO • Jun 17, 2025 8:00 AM
A.R.T. Digital Holdings (OTC: CGAC) Secures Non-Dilutive Financing for George West Site Supporting NASDAQ: BTBT • CGAC • Jun 17, 2025 5:07 AM
VAYK to Acquire Up to $9 million in Time-share Vacation Properties Through Non-Cash Deals • VAYK • Jun 11, 2025 9:45 AM